EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy

Kamika R Reynolds, Kimberly M O'Malley, Jason A Roy, Chintan V Dave

Annals of Internal Medicine · 2026

DOI: 10.7326/annals-25-00860 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Internal Medicine, 2026. Verfasst von Kamika R Reynolds und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2, Optic Neuropathy, Ischemic, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit nennt 35 Literaturangaben. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsDiabetes Mellitus, Type 2Optic Neuropathy, IschemicDipeptidyl-Peptidase IV InhibitorsSodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsHumansMaleMiddle AgedFemaleAdultAgedRisk FactorsYoung AdultAdolescentIncidence

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsDipeptidyl-Peptidase IV InhibitorsSodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents

Autor:innen und Institutionen

  • Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, New Jersey, and Center for Health Outcomes, Policy, and Economics, E…
  • Department of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, New Jersey (J.A.R.).

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NHLBI
  • NIDDK

Zitieren

APA

Reynolds, K. R., O'Malley, K. M., Roy, J. A., & Dave, C. V. (2026). Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy. Annals of Internal Medicine. https://doi.org/10.7326/annals-25-00860

Vancouver

Reynolds KR, O'Malley KM, Roy JA, Dave CV. Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy. Annals of Internal Medicine. 2026. doi:10.7326/annals-25-00860

BibTeX
@article{Reynolds2026,
  author = {Reynolds, Kamika R and O'Malley, Kimberly M and Roy, Jason A and Dave, Chintan V},
  title = {Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy},
  journal = {Annals of Internal Medicine},
  year = {2026},
  doi = {10.7326/annals-25-00860}
}
Kostenlos starten →